Abdullah A Al Qurashi1,2, Ahmed Kamal Siddiqi3, Abdulrahman Abdulaziz Alghamdi4, Abdullah Ali N Aljalfan5, Ahmed Abdullah Almenhali6, Faisal Ali Al Jabr7, Ahmed Mustafa Rashid8, Talal Almas9, Ritesh G Menezes4. 1. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia. 2. King Abdullah International Medical Research Center, Jeddah, Saudi Arabia. 3. Ziauddin Medical University, Karachi, Pakistan. ahmedsiddiqi2020@gmail.com. 4. College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. 5. College of Medicine, Imam Mohammad Ibn Saud University, Al Riyadh, Saudi Arabia. 6. Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. 7. King Faisal University, Al Ahsa, Saudi Arabia. 8. Jinnah Sindh Medical University, Karachi, Pakistan. 9. Royal College of Surgeons in Ireland, Dublin, Ireland.
Abstract
BACKGROUND AND AIM: Autologous fat transfer (AFT) has been introduced as a potential treatment option for scar-tissue and its related symptoms. However, the scientific evidence for its effectiveness remains unclear. This meta-analysis aims to evaluate the available evidence regarding the effectiveness of autologous fat transfer for the treatment of scar-tissue and its related conditions. METHODS: PubMed/Medline database was queried from its inception till the end of November 2021. All the relevant studies assessing the effect of autologous fat transfer in the treatment of scar-related conditions were pooled in using a random-effects model. RESULTS: 9 studies (n=179) were included in the meta-analysis. Pooled analysis demonstrates significant improvement in all subscales of the POSAS patient score with most prominent in color 2.4 points (95% CI 1.78-3.041), stiffness 2.9 points (95% CI 2.33-3.45), irregularity 2.2 points (95% CI 1.093-3.297) and thickness 1.8 points (95% CI 0.804-2.719), respectively. Pain and itch improved relatively lesser, 1.3 points (95% CI 0.958-1.674) and 0.6 points (95% CI 0.169-1.215), respectively. The POSAS observer scale showed a relatively lower improvement with the least in vascularity 0.5 points (95% CI 0.098-0.96), pigmentation 0.8 points (95% CI 0.391-1.276) and surface area 0.8 points (95% CI 0.34-1.25). Thickness improved by 1.4 points (95% CI 0.582-2.3), relief 1.0 points (95% CI 0.461-1.545) and pliability 1.5 points (95% CI 1.039-2.036). CONCLUSION: Our findings demonstrate that autologous fat transfer (AFT) is a promising treatment for scar-related conditions as it provides beneficial results in the scar quality. Future research should focus on the long-term effects of AFT and high-level evidence studies such as, randomized controlled trials (RCTs) and cohort studies are required. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
BACKGROUND AND AIM: Autologous fat transfer (AFT) has been introduced as a potential treatment option for scar-tissue and its related symptoms. However, the scientific evidence for its effectiveness remains unclear. This meta-analysis aims to evaluate the available evidence regarding the effectiveness of autologous fat transfer for the treatment of scar-tissue and its related conditions. METHODS: PubMed/Medline database was queried from its inception till the end of November 2021. All the relevant studies assessing the effect of autologous fat transfer in the treatment of scar-related conditions were pooled in using a random-effects model. RESULTS: 9 studies (n=179) were included in the meta-analysis. Pooled analysis demonstrates significant improvement in all subscales of the POSAS patient score with most prominent in color 2.4 points (95% CI 1.78-3.041), stiffness 2.9 points (95% CI 2.33-3.45), irregularity 2.2 points (95% CI 1.093-3.297) and thickness 1.8 points (95% CI 0.804-2.719), respectively. Pain and itch improved relatively lesser, 1.3 points (95% CI 0.958-1.674) and 0.6 points (95% CI 0.169-1.215), respectively. The POSAS observer scale showed a relatively lower improvement with the least in vascularity 0.5 points (95% CI 0.098-0.96), pigmentation 0.8 points (95% CI 0.391-1.276) and surface area 0.8 points (95% CI 0.34-1.25). Thickness improved by 1.4 points (95% CI 0.582-2.3), relief 1.0 points (95% CI 0.461-1.545) and pliability 1.5 points (95% CI 1.039-2.036). CONCLUSION: Our findings demonstrate that autologous fat transfer (AFT) is a promising treatment for scar-related conditions as it provides beneficial results in the scar quality. Future research should focus on the long-term effects of AFT and high-level evidence studies such as, randomized controlled trials (RCTs) and cohort studies are required. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Authors: Michael H Gold; Michael McGuire; Thomas A Mustoe; Andrea Pusic; Mukta Sachdev; Jill Waibel; Crystal Murcia Journal: Dermatol Surg Date: 2014-08 Impact factor: 3.398
Authors: Todor K Krastev; Sander J Schop; Juliette Hommes; Andrzej Piatkowski; Rene R W J van der Hulst Journal: J Plast Reconstr Aesthet Surg Date: 2020-08-20 Impact factor: 2.740
Authors: Vera L Negenborn; Jan-Willem Groen; Jan Maerten Smit; Frank B Niessen; Margriet G Mullender Journal: Plast Reconstr Surg Date: 2016-01 Impact factor: 4.730
Authors: J Christian Brown; Hulan Shang; Ning Yang; Justine Pierson; Catherine R Ratliff; Noah Prince; Nicholas Roney; Rodney Chan; Victoria Hatem; Haley Gittleman; Jill S Barnholtz-Sloan; Vladimir Vincek; Adam J Katz Journal: Plast Reconstr Surg Glob Open Date: 2020-05-27
Authors: Jip Beugels; Juliette E Hommes; Andrea J R Balthasar; René R W J van der Hulst; Andrzej A Piatkowski de Grzymala Journal: Plast Reconstr Surg Glob Open Date: 2018-08-16